Takeda Oncology

Kumquats

Biotech

Takeda inks sweet $1.2B-plus immuno-oncology deal with Kumquat

Takeda is offering Kumquat the chance to make $1.2-plus billion in a pact that centers around an unnamed immuno-oncology small-molecule inhibitor.

Gabrielle Masson Apr 16, 2024 11:34am

chutes ladders chutes AND ladders

Former CRISPR Tx CMO finds new home at Takeda

Feb 2, 2024 3:30pm

hot

ASCO: Takeda Oncology ready to stoke partnerships

Jun 9, 2022 7:30am